Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
- Conditions
- Colorectal Cancer Screening
- Interventions
- Diagnostic Test: FirstSight blood test
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- CellMax Life
- Target Recruit Count
- 1000
- Registration Number
- NCT05127096
- Locations
- 🇺🇸
CellMax Site K, Houston, Texas, United States
🇺🇸CellMax Site O, Chula Vista, California, United States
🇺🇸CellMax Site A, Huntsville, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath